Thomas A. Ciulla

Indiana University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Mark Barakat

Retina Macula Institute

UNITED STATES

View details

Christopher Adams

Novartis Institutes for BioMedical Research Inc

UNITED STATES

View details

Denis Jusufbegovic

Associate Professor

Indiana University Bloomington

UNITED STATES

View details

Szilard Kiss

Bob and Dolores Hope - Robert M. Ellsworth, M.D. Distinguished Associate Professor in Ophthalmology; Associate Dean, Clinical Compliance; Senior Councilor, General Faculty Council; Chief, Retina Service; Vice-Chair, Research; Vice-Chair, Compliance; Director, Tele-Ophthalmology

Weill Cornell Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas A. Ciulla

Research Interests

Explore related searches

Contact this professor

Articles (20)

Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial

Beyond the injection: delivery systems reshaping retinal disease management

Thyroid eye disease: revolutionizing treatment with IGF-1 receptor targeted therapy

Autoimmune neuro-ophthalmic disorders: pathophysiologic mechanisms and targeted biologic therapies

THREE-YEAR CLINICAL OUTCOMES IN GEOGRAPHIC ATROPHY

Safety and Efficacy of CLS-TA by Anatomic Location of Inflammation: Results from the Phase 3 PEACHTREE Clinical Trial

Suprachoroidal drug delivery: a versatile therapeutic platform

Long-acting delivery and therapies for neovascular age-related macular degeneration

Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and Beyond

Effect of Race and Insurance Status on Treatment and Outcomes in Diabetic Retinopathy: Analysis of 43 274 Eyes Using the IRIS Registry

The complement system: a novel therapeutic target for age-related macular degeneration

The evolving therapeutic landscape of diabetic retinopathy

OCT outcomes as biomarkers for disease status, visual function, and prognosis in diabetic macular edema

Triamcinolone Acetonide Suprachoroidal Injectable Suspension for Uveitic Macular Edema: Integrated Analysis of Two Phase 3 Studies

Aging Effects on Optic Nerve Neurodegeneration

Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques

Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications

Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema

Progress in the pharmacotherapy of uveitis: the art of personalized care

A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration

Collaborators (4)

Mark Barakat

Christopher Adams

Denis Jusufbegovic

Szilard Kiss

Make your next move.